[Federal Register Volume 63, Number 197 (Tuesday, October 13, 1998)]
[Notices]
[Page 54722]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-27381]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Sickle Cell Disease Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Sickle Cell Disease Advisory Committee.
    Date: November 13, 1998.
    Time: 9:00 AM to 5:00 PM.
    Agenda: To discuss recommendations on the implementation and 
evaluation of the NHLBI sickle cell disease program.
    Place: National Institutes of Health, Two Rockledge Center, 
Conference Room 9104, 6701 Rockledge Drive, Bethesda, MD 20892.
    Contact Person: Elaine Sloand, MD, Acting Director, Division of 
Blood Diseases and Resources, National Heart, Lung, and Blood 
Institute, Two Rockledge Center, Suite 10160, 6701 Rockledge Drive, 
Bethesda, MD 20892, (301/435-0080.

(Catalogue of Federal Domestic Assistance Program Nos. 93.839, Blood 
Diseases and Resources Research, National Institutes of Health, HHS)
    Dated: October 5, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-27381 Filed 10-9-98; 8:45 am]
BILLING CODE 4140-01-M